AMERGE Drug Patent Profile
✉ Email this page to a colleague
When do Amerge patents expire, and when can generic versions of Amerge launch?
Amerge is a drug marketed by Glaxosmithkline Llc and is included in one NDA.
The generic ingredient in AMERGE is naratriptan hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMERGE?
- What are the global sales for AMERGE?
- What is Average Wholesale Price for AMERGE?
Summary for AMERGE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 4 |
Patent Applications: | 475 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AMERGE |
What excipients (inactive ingredients) are in AMERGE? | AMERGE excipients list |
DailyMed Link: | AMERGE at DailyMed |
![AMERGE drug patent expirations Drug patent expirations by year for AMERGE](/p/graph/s/t/AMERGE-patent-expirations.png)
![Drug Prices for AMERGE](/p/graph/drug-price/AMERGE.png)
Recent Clinical Trials for AMERGE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hartford HealthCare | Phase 1/Phase 2 |
GlaxoSmithKline | |
GlaxoSmithKline | Phase 4 |
US Patents and Regulatory Information for AMERGE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | AMERGE | naratriptan hydrochloride | TABLET;ORAL | 020763-002 | Feb 10, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline Llc | AMERGE | naratriptan hydrochloride | TABLET;ORAL | 020763-001 | Feb 10, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AMERGE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | AMERGE | naratriptan hydrochloride | TABLET;ORAL | 020763-002 | Feb 10, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | AMERGE | naratriptan hydrochloride | TABLET;ORAL | 020763-001 | Feb 10, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AMERGE
See the table below for patents covering AMERGE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2069288 | ⤷ Sign Up | |
Hungary | 202225 | PROCESS FOR PRODUCING INDOLE DERIVATIVES | ⤷ Sign Up |
Singapore | 65393 | ⤷ Sign Up | |
Norway | 174052 | ⤷ Sign Up | |
Netherlands | 970035 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AMERGE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0303507 | C970035 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NARATRIPTAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAA RDBAAR ZOUT OF SOLVAAT, IN HET BIJZONDER NARATRIPTAN-HYDROCHLOR IDE; NAT. REGISTRATION NO/DATE: RVG 21444 19970801; FIRST REGISTRATION: SE 13382 19970310 |
0303507 | 97C0102 | Belgium | ⤷ Sign Up | PRODUCT NAME: NARATRIPTAN HYDROCHLORIDUM; REGISTRATION NO/DATE: 725 IS 278 F 3 19970818; FIRST REGISTRATION: SE 13382 19970310 |
0303507 | 64/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: ''NARATRIPTAN'', GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER SOLVATES EINSCHLIESSLICH DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: 1-22059 19970731; FIRST REGISTRATION: SE 13382 19970310 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |